S. Joshua Swamidass

Swamidass published a book in 2019 based on implications of recent universal genealogical ancestry regarding the theology of the image of God, the fall, and people outside the garden.[8] In his interview with “BibleProject Podcast”, he discussed the differences between genealogical ancestry and genetic ancestry, and explored the conflict that exists between evolutionary science and creationism. Furthermore, he stated "The genealogical account does not prove [Adam and Eve’s existence], but it’s impossible to disprove the existence of such a couple 6,000 years ago."[9] Anjeanette Roberts praised Swamidass’ work and stated that in his book the emphasis on "genealogical ancestry is so clearly biblical that its long-term absence in evangelical conversations about human origins is shocking" and the work also helps to remove "the enmity and barriers that divide scientists, theologians, exegetes, evolutionists, and creationists."[10] Nathan H. Lents described the book as "a bold new attempt to reconcile the biblical story of Adam and Eve with what we know about the genetic ancestry of the human race."[11]

In his studies of chemical informatics, Swamidass introduced three new kernels: Tanimoto, MinMax, and Hybrid, based on the idea of molecular fingerprints. He studied the properties and tradeoffs of these kernels, and also discussed their applications in terms of predicting mutagenicity, toxicity, and anti-cancer activity on three publicly available data sets.[12] In 2013, he demonstrated that artificial intelligence algorithms can predict metabolic transformations of xenobiotic molecules, and highlighted the role of these processes in the safety, efficacy, and dose of medicines.[13] He also developed and explored algorithms regarding fast exact searches of chemical fingerprints in linear and sub-linear time.[14] He, along with co-authors developed a novel screening method, Influence Relevance Voter (IRV), and provided its advantages over other SVMs and other methods.[15] Moreover, he focused his study to highlight opportunities and obstacles for deep learning in biology and medicine.[16]

Swamidass studied drug metabolism,[17] described its impacts in the context of patient morbidity and mortality, and provided new directions such as joint metabolism and reactivity modeling.[18] While focusing on open source drug discovery with the malaria box, he suggested mechanisms of action for the compounds active in killing multiple life-cycle stages of the malaria parasite, and also defined the processes to catalyze drug discovery for dozens of different indications.[19]

• The Genealogical Adam and Eve: The Surprising Science of Universal Ancestry (2019) ISBN 9780830865055

• Swamidass, S. J., Chen, J., Bruand, J., Phung, P., Ralaivola, L., & Baldi, P. (2005). Kernels for small molecules and the prediction of mutagenicity, toxicity and anti-cancer activity. Bioinformatics, 21(suppl_1), i359-i368.
• Swamidass, S. J., Chen, J., Bruand, J., Phung, P., Ralaivola, L., & Baldi, P. (2005). Kernels for small molecules and the prediction of mutagenicity, toxicity and anti-cancer activity. Bioinformatics, 21(suppl_1), i359-i368.
• Ralaivola, L., Swamidass, S. J., Saigo, H., & Baldi, P. (2005). Graph kernels for chemical informatics. Neural networks, 18(8), 1093-1110.
• Li, J., Zheng, S., Chen, B., Butte, A. J., Swamidass, S. J., & Lu, Z. (2016). A survey of current trends in computational drug repositioning. Briefings in bioinformatics, 17(1), 2-12.
• Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., ... & Greene, C. S. (2018). Opportunities and obstacles for deep learning in biology and medicine. Journal of The Royal Society Interface, 15(141), 20170387.